Skip to main content

Co-Diagnostics, Inc.

corporate_fare Company Profile

Co-Diagnostics, Inc.

CODX·NASDAQ·Industrial Applications And Services·CIK 0001692415

Co-Diagnostics, Inc. develops, manufactures, and sells reagents for diagnostic tests that detect and analyze nucleic acid molecules (DNA or RNA), including molecular tools for infectious diseases. The company's diagnostic systems aim to provide dependable, low-cost molecular testing by simplifying complex procedures in test development and administration. Co-Diagnostics' technology uses a proprietary approach to polymerase chain reaction (PCR) test design, called Co-Primers®, which reduces primer-dimer amplification (false positives) that can interfere with identifying target DNA/RNA. Using this system and reagents, the company has designed and obtained regulatory approval to sell PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the Zika virus. These initial diagnostic tests are cleared for use only in clinical labs. Co-Diagnostics has also developed a portable diagnostic device and test system for point-of-care and at-home use, referred to as the "Co-Dx™ PCR platform." This system includes the Co-Dx™ PCR Pro® instrument, a patent-pending diagnostic test cup system, and a mobile application. The Co-Dx PCR platform is designed to offer affordable, reliable PCR testing in point-of-care and at-home settings. This platform is currently subject to U.S. Food and Drug Administration (FDA) review and is not available for sale at the time of this filing. In June 2024, the company completed its first FDA 510(k) clearance application for the Co-Dx PCR Pro instrument, the Co-Dx PCR COVID-19 Test, and the Co-Dx PCR mobile app for over-the-counter (OTC) use.

Co-Diagnostics, Inc. (NASDAQ:CODX) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 36 items for CODX at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-20, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 9 rated 8 or above. Recent SEC coverage for CODX spans 8-K, 10-Q, S-3, DEF 14A.

Recent high-impact activity:

  • Co-Diagnostics Draws Second $1M J.J. Astor Tranche at 1.35x Factor, Netting $960K
  • Co-Diagnostics Sets 1-for-25 Reverse Split Effective Nov. 24 to Chase Nasdaq $1.00 Bid
  • Co-Diagnostics Holders Approve Reverse-Split Authority, Warrant Exercise and 2M-Share Plan Increase
  • Co-Diagnostics Q3: Cash Falls to $715K, Going Concern Reaffirmed, J.J. Astor Loan Sweeps ATM Proceeds
  • Co-Diagnostics Posts $1.01 Per-Share Q3 Loss as Cash Crunch Deepens

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$622.49K
Net Income
-$46.9M
Diluted EPS
-$35.25
Op. Cash Flow
-$29.14M
Free Cash Flow
-$29.84M
Gross Profit
$400.11K
Operating Income
-$50.17M
Cash & Equivalents
$11.88M
Debt / Equity
0.00×
Net Margin
-75.34×
Shares Outstanding
2.1M sh
Source: 10-K · filed 2026-03-31 · accession 0001493152-26-014158

Short Interest & Short Volume

2.24 days to cover

FINRA reported short interest of 981,329 shares in CODX as of the October 30, 2026 settlement, a 49.5% increase from the prior period — about 2.2 days to cover at its recent average daily volume. On November 20, 2026, 56.3% of CODX volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)981,329 shares as of October 30, 2026
Change vs prior period▲ 49.5%
Days to cover2.24 at avg daily volume of 438,760
Daily short volume (FINRA facilities)56.3% of 573,935 shares on November 20, 2026
5-day average short volume42.2%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

Moderate risk

Filing-implied dilution signals for CODX, detected from its recent SEC filings · based on capital-structure filings through 2026-11-04.

1 recent capital raiseATM program3 shelf registrations

ATM Program Activated · Dilution Overhang

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with C →
$0.1332 +2.86% today
52-week range · as of 2026-11-20 $0.1276 – $13.54
Market cap
$1.36M
Volume
1.1M (0.3× avg)
3-mo avg 4M
Live data · 2026-11-21 05:18 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed CODX - Latest Insights

CODX
Nov 20, 2026, 4:30 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.140
Real-time Price: $0.1332 info
Change: Reverse Stock Split info
Market Cap: $1.361M info
CODX
Nov 19, 2026, 5:00 PM EST
Source: Wiseek News
Importance Score:
7
Updated Nov 19, 5:11 PM ET — Co-Diagnostics filed the Articles of Amendment on November 19, 2026; post-split shares will trade under new CUSIP 189763 303, with about 52…
Price at Filing: $0.1657
Real-time Price: $0.1332 info
Change: Reverse Stock Split info
Market Cap: $1.361M info
CODX
Nov 13, 2026, 5:00 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.2585
Real-time Price: $0.1332 info
Change: Reverse Stock Split info
Market Cap: $1.361M info
CODX
Nov 10, 2026, 4:05 PM EST
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.2856
Real-time Price: $0.1332 info
Change: Reverse Stock Split info
Market Cap: $1.361M info
CODX
Nov 10, 2026, 8:00 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $0.3652
Real-time Price: $0.1332 info
Change: Reverse Stock Split info
Market Cap: $1.361M info
CODX
Nov 04, 2026, 4:45 PM EST
Filing Type: S-3
Importance Score:
8
Price at Filing: $0.3615
Real-time Price: $0.1332 info
Change: Reverse Stock Split info
Market Cap: $1.361M info
CODX
Oct 26, 2026, 4:00 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $0.5459
Real-time Price: $0.1332 info
Change: Reverse Stock Split info
Market Cap: $1.361M info
CODX
Oct 19, 2026, 12:28 PM EDT
Filing Type: PRE 14A
Importance Score:
8
Price at Filing: $0.6726
Real-time Price: $0.1332 info
Change: Reverse Stock Split info
Market Cap: $1.361M info
CODX
Oct 15, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.7201
Real-time Price: $0.1332 info
Change: Reverse Stock Split info
Market Cap: $1.361M info
CODX
Oct 13, 2026, 6:10 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.23
Real-time Price: $0.1332 info
Change: Reverse Stock Split info
Market Cap: $1.361M info
CODX
Sep 21, 2026, 5:02 PM EDT
Filing Type: PRE 14A
Importance Score:
8
Price at Filing: $1.00
Real-time Price: $0.1332 info
Change: Reverse Stock Split info
Market Cap: $1.361M info
CODX
Aug 13, 2026, 4:10 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $1.49
Real-time Price: $0.1332 info
Change: Reverse Stock Split info
Market Cap: $1.361M info
CODX
Aug 13, 2026, 4:03 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.47
Real-time Price: $0.1332 info
Change: Reverse Stock Split info
Market Cap: $1.361M info
CODX
Aug 13, 2026, 4:01 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $1.49
Real-time Price: $0.1332 info
Change: Reverse Stock Split info
Market Cap: $1.361M info
CODX
Jul 31, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.65
Real-time Price: $0.1332 info
Change: Reverse Stock Split info
Market Cap: $1.361M info
CODX
Jul 28, 2026, 8:00 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $2.06
Real-time Price: $0.1332 info
Change: Reverse Stock Split info
Market Cap: $1.361M info
CODX
Jul 27, 2026, 5:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.03
Real-time Price: $0.1332 info
Change: Reverse Stock Split info
Market Cap: $1.361M info
CODX
Jul 27, 2026, 5:03 PM EDT
Filing Type: 424B5
Importance Score:
7
Price at Filing: $2.04
Real-time Price: $0.1332 info
Change: Reverse Stock Split info
Market Cap: $1.361M info
CODX
Jul 22, 2026, 9:00 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $2.53
Real-time Price: $0.1332 info
Change: Reverse Stock Split info
Market Cap: $1.361M info
CODX
Jul 09, 2026, 6:18 PM EDT
Filing Type: PRE 14A
Importance Score:
7
Price at Filing: $2.60
Real-time Price: $0.1332 info
Change: Reverse Stock Split info
Market Cap: $1.361M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets